Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/39552
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCheng, Yue Xiang.-
dc.date.accessioned2010-05-31T03:52:43Z-
dc.date.available2010-05-31T03:52:43Z-
dc.date.copyright2010en_US
dc.date.issued2010-
dc.identifier.urihttp://hdl.handle.net/10356/39552-
dc.description.abstractParkinson’s disease (PD) is a prevalent neurodegenerative disorder affecting millions of elderly worldwide. Although most cases of PD are idiopathic, a small proportion is caused by genetic mutations. Among these, mutations in Leucine Rich Repeat Kinase 2 (LRRK2) have been shown to be the most prevalent cause of familial PD, with the G2019S variant being the most common. Several groups have demonstrated that mutations in LRRK2 increase its kinase activity and result in neurotoxicity. One of the few substrates of LRRK2 that has been identified to date is 4E-BP, a regulator of protein translation. When 4E-BP is phosphorylated, it initiates CAP-dependent protein translation that drives the expression of many proteins including cyclin D1. Kinase activating mutations of LRRK2 lead to hyperphosphorylation of 4E-BP and thereby de-regulated protein translation. In my current study, I have exploited this property of LRRK2 and created a cyclin D1 5’ UTR-based reporter assay to measure LRRK2-induced protein translation. Using this system as a basis for drug screening, I found that EGCG, a green tea-derived catechin, mitigates LRRK2 G2019S-mediated enhancement of protein translation by reducing the levels of p4E-BP. My results provided proof-of-concept that the reporter system that I have developed would be useful for drug screening. Notably, a parallel study done in my supervisor’s laboratory has confirmed the neuroprotective effects of EGCG against LRRK2-induced neurotoxicity in vivo. Taken together, I have demonstrated here the successful development of a screening tool for compounds of potential therapeutic value to LRRK2-related PD patients.en_US
dc.format.extent30 p.en_US
dc.language.isoenen_US
dc.rightsNanyang Technological University-
dc.subjectDRNTU::Science::Biological sciences::Human anatomy and physiology::Neurobiologyen_US
dc.titleUnderstanding the role of LRRK2 in protein translation - implications for Parkinson's disease.en_US
dc.typeFinal Year Project (FYP)en_US
dc.contributor.schoolSchool of Biological Sciencesen_US
dc.description.degreeBachelor of Science in Biological Sciencesen_US
dc.contributor.organizationNational Neuroscience Instituteen_US
dc.contributor.supervisor2Lim Kah Leongen_US
item.grantfulltextrestricted-
item.fulltextWith Fulltext-
Appears in Collections:SBS Student Reports (FYP/IA/PA/PI)
Files in This Item:
File Description SizeFormat 
yuexiang.pdf
  Restricted Access
698.05 kBAdobe PDFView/Open

Google ScholarTM

Check

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.